Clinical success with allograft use has been reported for the treatment of soft tissue and gingival augmentation. Tissue grafts such as Oracell® are used to provide new gingiva and cover the root.
Allograft bone blocks are a proven alternative to autogenous grafts which have several disadvantages including prolonged operation times, limited graft availability, and risk of damage to adjacent teeth. LifeNet Health’s Dental Allograft Solutions include structural and particulate grafts which provide strength and stability for predictable new bone formation of the alveolar ridge.
Almost 50% of adults 30 years and older have some form of periodontal disease and the prevalence increases with age. The global economic burden of periodontal disease remains high. The ultimate goal of periodontal therapy relies on the restoration of all components of the periodontium to their original architecture and function (not just bone stabilization).
Allografts can be used for sinus augmentation, maxillofacial reconstruction and correction of periodontal and ridge defects. Our tissue allografts are clinically proven in multiple applications. As a result, we are the world's most trusted provider of transplant solutions, from new innovations in tissue grafts and technologies to regenerative medicine and cellular therapies. Since 1995, more than 8 million allografts processed using Allowash® technology have been distributed by LifeNet Health with no disease transmission. 1-4
Use of ViviGen® Cellular Bone Allograft
In Orthopaedic Trauma – Do We Even Need Iliac Crest Anymore?
CardioGRAFT® allografts are the ideal solution for optimal cardiac repair and reconstruction.
Donated human-tissue grafts most closely resemble native tissue and are more resistant to infection than synthetics.1-3 Thanks to LifeNet Health's advanced processing techniques, these grafts consistently perform as they should, alleviating the need for anticoagulation therapy4 and reducing thrombotic potential.3
The Global Dental Symposium Series is designed to bring leading minds together to share the latest data and techniques that will enhance patient care. The series comprises 30+ engaging opportunities from renowned clinicians around the world.
To review the complete library of previous sessions, please click here.
To register for an upcoming session, please click below.
AngioGraft® allograft vessels are the natural choice for managing vascular reconstruction.
The clinical efficacy of CardioGraft-MC® patches is supported by a growing number of peer-reviewed clinical publications and industry event educational seminars. In addition to the clinical efficacy of a graft, cost considerations are equally important when deciding on a graft to use for your case as costs do not stop at the index procedure. Reoperations carry a risk of financial burden for patients and facilities, which are often not fully reimbursed for procedures.
